Neuronetics Inc (STIM): A Technical Analysis

STIM has 36-month beta value of 2.14. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”

The public float for STIM is 3.21M, and currently, short sellers hold a 40.02% ratio of that float. The average trading volume of STIM on February 24, 2025 was 1.05M shares.

STIM) stock’s latest price update

Neuronetics Inc (NASDAQ: STIM)’s stock price has dropped by -13.96 in relation to previous closing price of 4.80. Nevertheless, the company has seen a gain of 5.90% in its stock price over the last five trading days. globenewswire.com reported 2025-02-07 that MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 15,750 shares of the Company’s common stock (RSUs) to two new non-executive employees. In accordance with NASDAQ Listing Rule 5635(c)(4), these awards were approved by Neuronetics’ Compensation Committee and made as material inducements to their respective employment with the Company.

STIM’s Market Performance

STIM’s stock has risen by 5.90% in the past week, with a monthly rise of 75.74% and a quarterly rise of 428.81%. The volatility ratio for the week is 14.57% while the volatility levels for the last 30 days are 14.01% for Neuronetics Inc The simple moving average for the past 20 days is 13.67% for STIM’s stock, with a 147.65% simple moving average for the past 200 days.

STIM Trading at 69.95% from the 50-Day Moving Average

After a stumble in the market that brought STIM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.54% of loss for the given period.

Volatility was left at 14.01%, however, over the last 30 days, the volatility rate increased by 14.57%, as shares surge +72.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +225.20% upper at present.

During the last 5 trading sessions, STIM rose by +5.90%, which changed the moving average for the period of 200-days by +8.40% in comparison to the 20-day moving average, which settled at $3.63. In addition, Neuronetics Inc saw 156.52% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at STIM starting from Sullivan Keith J, who sale 24,440 shares at the price of $4.70 back on Feb 19 ’25. After this action, Sullivan Keith J now owns 1,232,988 shares of Neuronetics Inc, valued at $114,868 using the latest closing price.

Sullivan Keith J, the President and CEO of Neuronetics Inc, sale 25,934 shares at $4.41 during a trade that took place back on Feb 18 ’25, which means that Sullivan Keith J is holding 1,257,428 shares at $114,369 based on the most recent closing price.

Stock Fundamentals for STIM

Current profitability levels for the company are sitting at:

  • -0.38 for the present operating margin
  • 0.74 for the gross margin

The net margin for Neuronetics Inc stands at -0.5. The total capital return value is set at -0.48. Equity return is now at value -153.94, with -43.59 for asset returns.

Based on Neuronetics Inc (STIM), the company’s capital structure generated 0.84 points at debt to capital in total, while cash flow to debt ratio is standing at -0.42. The debt to equity ratio resting at 5.19. The interest coverage ratio of the stock is -3.73.

Currently, EBITDA for the company is -22.76 million with net debt to EBITDA at -1.03. When we switch over and look at the enterprise to sales, we see a ratio of 2.66. The receivables turnover for the company is 3.77for trailing twelve months and the total asset turnover is 0.98. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.16.

Conclusion

To put it simply, Neuronetics Inc (STIM) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Most Popular

Related Posts